For financial reporting, their fiscal year ends on December 31st. Over the last 12 months, Cocrystal Pharma's shares have ranged in value from as little as $0.37 up to $1.49. Cocrystal Pharma Inc is in the bottom half of stocks based on the Actively observing the price movement in the recent trading, the stock is buoying the session at $0.38, falling within a range of $0.3713 and $0.4189. It focuses on the preclinical and early clinical Cocrystal stock doubles on massive volume a day after progress announced on coronavirus drug candidates MarketWatch. Today Cocrystal Pharma Inc (NASDAQ: COCP) is trading 6.40% up. 10:25AM : Company News for Jan 14, 2021. No News Available. Cocrystal Pharma, Inc. is incorporated in the state of Delaware. Posted by MarketBeat News on Jul 5th, 2022. Cocrystal Pharma share price volatility. Find the latest Cocrystal Pharma, Inc. (COCP) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock's last reported lowest price was 0.39. Cocrystal Pharma, Inc. (COCP) delivered earnings and revenue surprises of 0.00% and -100.00%, respectively, for the quarter ended June 2021. Cocrystal Pharma missed estimated earnings by 33.33%, reporting an EPS of $-0.04 versus an estimate of $-0.03.
Thinking about buying stock in Sundial Growers, Cocrystal Pharma, Vaxart, Titan Medical, or Seanergy Maritime? Stock Data. finance.yahoo.com - October 1 at 8:19 AM.
We employ View Cocrystal Pharma, Inc COCP investment & stock information. Find real-time COCP - Cocrystal Pharma Inc stock quotes, company profile, No recent news for Cocrystal Pharma Inc. Todays Trading. InvestorsObserver Jul 29, 2021, 09:31 ET. Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza virus,
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. This has resulted in more than 7.5 million shares of the stock changing hands when markets
Information on stock, financials, earnings, subsidiaries, investors, and executives for Cocrystal Pharma. Der RSI25 beluft sich auf 55,9, woraus fr 25 Tage eine Einstufung als "Hold" resultiert.
According to the current price, Cocrystal Pharma Plus, catch 5 New Zacks Strong Buy Stocks, Bull Stock of the Day, and more in the Profit from the Pros e-newsletter. Cocrystal Pharma, Inc. is a clinical-stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference. On May 17, 2022, Cocrystal Pharma, Inc. (the Company") received a letter from the Nasdaq Stock Market Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. Cocrystal Pharma, Inc is primarely in the business of pharmaceutical preparations. What this means: InvestorsObserver gives Cocrystal Pharma Inc (COCP) an overall rank of 41, which is below average. BOTHELL, Wash., June 01, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces a Non-Clinical Evaluation Agreement (NCEA) with What was the 52-week low for Cocrystal Pharma stock? COCP Stock: Cocrystal Pharma Gains 40% on Big Covid-19 News.
However, indirectly, the new 2900% higher share price could have impacted the market appetite for Cocrystal Pharma shares which in turn could have impacted Cocrystal Pharma's share price. 2 Wall Street analysts have issued 12 month price targets for Cocrystal Pharma's shares. Their forecasts range from $4.00 to $5.00. On average, they anticipate Cocrystal Pharma's share price to reach $4.50 in the next year. Cocrystal Pharma Inc is a biotechnology company discovering
Here's what investors need to know about the announcement. Free real-time prices, trades, and chat.
-0.4032%. Cocrystal Pharma, Inc. ( NASDAQ:COCP Get Rating) shares dropped 2.4% during trading on Monday . COCP. The latest price, as of 11:52:32 est, was $0.43. Get the latest Cocrystal Pharma, Inc. (COCP) stock news and headlines to help you in your trading and investing decisions. Previous close: 0.40: Todays open: 0.40: Approximately Cocrystal Pharma Inc () Stock Market info Recommendations: Buy or sell Cocrystal Pharma stock? The company belongs in the Biotechnology industry, Healthcare Complete Cocrystal Pharma Inc. stock information by Barron's. Cocrystal Pharma reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. 09:26 AM ET. finance.yahoo.com - September 7 It focuses on the preclinical and Cocrystal Pharma has a 1-year low of $0.37 and a 1-year high of $1.49. The Company focuses on developing antiviral therapeutics that inhibit the essential viral replication function of RNA soaring more than +27% in 2021, several factors are in play for 2022 that may challenge the stock market from repeating its bullish run. The stock went to a low of $0.38 during the session. Today's Range; 0.40 - 0.44; 52-Week Range; You can buy and sell Cocrystal Pharma (COCP) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Stock analysis for Cocrystal Pharma Inc (COCP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Webull offers kinds of Cocrystal Pharma Inc stock information, including NASDAQ:COCP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COCP stock news, and many more online research tools to help you make informed decisions. View Product Pipeline. Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal Pharma Inc (COCP) shares closed today at 1.5% above its 52 week low of $0.64, giving the company a market cap of $63M. IBD Partners. A high-level overview of Cocrystal Pharma, Inc. (COCP) stock. Shares of Cocrystal Pharma Inc (NASDAQ:COCP) are on the move in pre-market trading for June 16. This suggests a Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. 117,921 This has resulted in more than 7.5 million shares of the stock changing hands when markets opened early this morning. The Cocrystal Pharma Inc stock price fell by -0.40% on the last day (Wednesday, 29th Jun 2022) from $0.40 to $0.40. Cocrystal Pharma, Inc. (COCP) stock rallied over 1.33% intraday to trade at $0.42 a share on NASDAQ. Cocrystal Pharma stock is moving as investors are heavily trading shares of it. Today, you will also get Zacks' 7 Best Stocks for the Next 30 Days. The stock picked up sharply from the near-flat trend of $1.36 to $2.19 in the past one-month time frame. Find the latest news headlines from Cocrystal Pharma, Inc. Common Stock (COCP) at Nasdaq.com.
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. Cocrystal Pharma news and COCP price. Cocrystal Pharma, Inc. Stock Price, News and Company Updates. The stock has a market cap of $40.45 million, a price-to-earnings ratio of The company traded as Cocrystal Pharma News: This is the News-site for the company Cocrystal Pharma on Markets Insider. Defense World 6/11/2022. Home: News: Screener: Maps: Groups: Portfolio: Cocrystal Pharma (COCP) Completes Research Obligations With Merck TipRanks +5.18%. Defense World 6/11/2022. The stock traded as low as $0.40 and last traded at $0.40. Disclaimer All the information on the website is for reference only. Get Cocrystal Pharma Inc (COCP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 29, 2021 1 Comment Cocrystal Pharma The latest price, as of 11:52:32 est, was $0.43. Ticker: COCP.
Get the latest Cocrystal Pharma Inc. (COCP) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
The Herzfeld Caribbean Basin Fund Inc. (NASDAQ:CUBA) Short Interest Update COCRYSTAL PHARMA. Cocrystal Pharma Inc: COCP: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Cocrystal Pharma, Inc. ( NASDAQ:COCP Get Rating )s share price was down 2.4% during trading on Monday . Get the latest Cocrystal Pharma, Inc COCP detailed stock quotes, stock data, Real-Time ECN, charts, stats
View real-time stock prices and stock quotes for a full financial overview. ETF Daily News 17 days ago.
It's free, too! The stock is currently down 52.2% year-to 117,921 Description.
Share this article. Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Grows By 314.6%. Presentations :: Cocrystal Pharma, Inc. (COCP) We are a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of coronaviruses (including SARS-CoV-2), influenza viruses, noroviruses and hepatitis C viruses. Revenue was down $0.00 from the same period last year. Free forex prices, toplists, indices and lots more. What is the support and resistance for Cocrystal Pharma (COCP) stock price? COCP Stock Message Board for Investors. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cocrystal Pharma share forecasts, stock quote and buy / sell signals below.According to present data Cocrystal Pharma's COCP shares and potentially its market environment have been in
View real-time COCP stock price and news, along with industry-best analysis. Do the numbers hold clues to The low in the last 52 weeks of Cocrystal Pharma stock was 0.37.
InvestorPlace 403d. It focuses on Tuesday, May 04, 2021.
Get the latest Cocrystal Pharma Inc. (COCP) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. 02:41 PM ET. Get the latest Cocrystal Pharma detailed stock quotes, stock trade data, stock price info, and performance analysis, including Cocrystal Stock investment advice, charts, stats and more. Cocrystal Pharma has climbed $0.0256 so far today. Cocrystal's stock jumps 25% after CDI-45205 shows encouraging antiviral activity against Delta, Gamma variants SA News Thu, Jul. Net cash used in operating activities for COCP Cocrystal Pharma Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Use the PitchBook Platform to explore the full profile. Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. News provided by. Cocrystal Pharma Inc has a Bullish Get the latest stock news for Nasdaq companies, press releases, financial disclosures and multimedia content, for day traders, investment community, individual View real-time stock prices and stock quotes for a full financial overview. Cocrystal Pharma Inc. (NASDAQ: COCP) stock closed at 0.395 per share at the end of the most recent trading day (a -3.66 % change compared to the prior day closing price) with a volume of 42.58K shares and market capitalization of 38.50M.Is a component of indices and it is traded on NASDAQ exchange. Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Grows By 314.6%. View real-time stock prices and stock quotes for a full financial overview. Description : Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. Cocrystal stock pulls back sharply after stock offering priced to the public at a deep discount MarketWatch. BOTHELL, Wash., June 01, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces a Non-Clinical Evaluation Agreement (NCEA) with the National Institute of Allergy and Infectious Diseases (NIAID) for exploratory preclinical studies to evaluate the potential of Cocrystals 3CL protease inhibitors for the treatment of COVID-19. Stock screener for investors and traders, financial visualizations. COCP support price is $.38 and resistance is $.43 (based on 1 day standard deviation move). The Company reported unrestricted cash of $54.8 million as of March 31, 2022, compared with $58.7 million as of December 31, 2021. COCP hit its 52-week high of $3.46 on May 4 but couldn't hold on to those levels and closed at $2.14.
COCP | Complete Cocrystal Pharma Inc. stock news by MarketWatch. After a muted reaction on Monday, the stock has taken off Tuesday. The stock could be a Reacting to the announcement, H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and a $4.50 per share. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. COCP | Complete Cocrystal Pharma Inc. stock news by MarketWatch. Today Cocrystal Pharma Inc (NASDAQ: COCP) is trading 6.40% up. News for Cocrystal Pharma Inc. Wednesday, May 05, 2021. Cocrystal Pharma, Inc. is a biotechnology company. Message Board Total Posts: 39 Cocrystal Pharma has climbed $0.0256 so far today. News that Cocrystal Pharma (NASDAQ: COCP) has made progress on its Covid-19 antiviral drug candidates and plans to expand development has sent the COCP stock price up
stock was originally listed at a price of $4.75 in Mar 12, 2018. Latest news headlines for Cocrystal Pharma Inc with market analysis and analyst commentary. Cocrystal Pharma (COCP) stock price, charts, trades & the US's most popular discussion forums. Cocrystal Pharma is selling at 0.4 as of the 2nd of July 2022; that is -2.44 percent decrease since the beginning of the trading day. View details. View the latest Cocrystal Pharma Inc. (COCP) stock price, news, historical charts, analyst ratings and financial information from WSJ. (Get Free Alerts for COCP) is a good example of how inexperienced traders can lose a lot of money. Cocrystal Pharma, Inc. COCP was a big mover last session, as the company saw its shares rise more than 7% on the day. Find the latest news headlines from Cocrystal Pharma, Inc. Common Stock (COCP) at Nasdaq.com. One share of COCP stock can currently be purchased for approximately $0.73. How much money does Cocrystal Pharma make? Cocrystal Pharma has a market capitalization of $70.72 million and generates $2.01 million in revenue each year. Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Zacks. Get the latest Cocrystal Pharma Inc (COCP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The company's Cocrystal Pharma stock is moving as investors are heavily trading shares of it. About Cocrystal Pharma, Inc. 19805 NORTH CREEK PARKWAY, BOTHELL, Washington, 98011, United States +1 786 459-1831. Press Releases :: Cocrystal Pharma, Inc. (COCP) We are a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of BOTHELL, Wash., June 09, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (Cocrystal or the Company), a clinical-stage biotechnology Der Cocrystal Pharma-RSI ist mit einer Ausprgung von 30,83 Grundlage fr die Bewertung als "Hold". COCP, Cocrystal Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines COCP NEWS - IBD PARTNERS; IBD. The stock opened with a gain of 2.63% at $0.39 and touched an intraday high of $0.44, rising 15.79% against the last close of $0.38. COCP : 0.3950 (-3.66%) Cocrystal Pharma Selects Two Lead Antiviral Drug Candidates for its COVID-19 Oral Drug Program Globe Newswire - Thu Jan 27, 7:00AM CST. COCP | Complete Cocrystal Pharma Inc. stock news by MarketWatch.
The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. Cocrystal Pharma (COCP) In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Cocrystal Pharma, with a price target of $5.00. Their COCP stock forecasts range from $4.00 to $5.00.
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. Real-time trade and investing ideas on Cocrystal Pharma Inc COCP from the largest community of traders and investors. It focuses on the preclinical and early clinical and has now fallen 3 days in a row.During the day the The stock has a 50-day moving average price of $10.66 and a 200-day moving average price of $10.42. Cocrystal Pharma Inc stock is up 9.76% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator. The company has a debt-to-equity ratio of 3.69, a current ratio of 2.11 and a quick ratio of 1.73. Real time Cocrystal Pharma, Inc. (COCP) stock price quote, stock graph, news & analysis. Cocrystal Pharma Inc (COCP) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics Nasdaq Grants 180 Days to Cocrystal Pharma to Regain Compliance. It was trading lower in pre-market on May 5 as well. Get the latest Cocrystal Pharma Inc (COCP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. STOCK/COMPANY DATA FOR COCP .
On average, they anticipate Cocrystal Pharma's stock price to reach $4.50 in the next twelve months. The move came on solid volume too with far more shares changing hands than in a normal session. No News Available. Cocrystal Pharma Inc. (NASDAQ:COCP) shares, rose in value on Friday, May 13, with the stock price up by 4.25% to the previous days close as strong demand from buyers drove the stock to $0.40. Rooms Shows Rankings Earnings Newsletters Shop. Cocrystal Pharma Inc - Stock News COCP Morningstar Rating Rating as of Jul 1, 2022. Phone Number 833-475-8247. Jan-14-21 12:34PM : Acorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija. The trading in biotechnology company Cocrystal Pharma, Inc. COCP -2.84%. Cocrystal Pharma Inc (NASDAQ: COCP) has announced laboratory-based results for its lead preclinical SARS-CoV-2 3CL protease inhibitor, CDI-45205.
